In Nigeria, the dual challenge of low coverage and inequitable access, particularly in the northern part of the country, has led to low immunization coverage, making the populous nation one of the largest contributors to the global burden of vaccine-preventable illnesses and deaths (VPDs). Lack of political will, insufficient organizational capacity and inadequate funding were … Continued
Focus Area: <span>Maintaining political will and commitment during transition</span>
Results 1 -10 of 17
LNCT Materials to Help you Make the Case for Investing in Immunization
Why We Need to Make a Case for Investment
Maintaining a high performing immunization program requires sustained commitment and funding over time. Ongoing communication and advocacy are needed to maintain investments and to stimulate additional investments to achieve health goals. Advocating for resources for immunization at national and sub-national levels requires demonstrating the health and economic impact of proposed investments to convince decision makers to allocate funding for immunization.
… ContinuedRe-evaluating the Potential Impact and Cost-effectiveness of Rotavirus Vaccination in 73 Gavi Countries: A Modelling Study
Background
Previous studies have found rotavirus vaccination to be highly cost-effective in low-income countries. However, updated evidence is now available for several inputs (ie, rotavirus disease mortality rates, rotavirus age distributions, vaccine timeliness, and vaccine efficacy by duration of follow-up), new rotavirus vaccines have entered the market, vaccine prices have decreased, and cost-effectiveness thresholds have been re-examined. We aimed to provide updated cost-effectiveness estimates to inform national decisions about the new introduction and current use of rotavirus vaccines in Gavi countries. … Continued
Rotavirus Vaccination is Cost Effective and Saves Lives, New Analysis Finds
In an analysis published in the December issue of The Lancet Global Health, investigators from PATH, the London School of Hygiene & Tropical Medicine, and the US Centers for Disease Control and Prevention, analyzed the potential costs of rotavirus vaccination for 10 successive birth cohorts (from 2018 through 2027) in 73 countries eligible for Gavi support, compared … Continued
Georgia’s Introduction of the Hexavalent Vaccine: Lessons on Successful Procurement and Advocacy
This blog is also available in Russian.
Authors: Eka Paatashvili and Vladimer Getia
As countries transition from Gavi support, sustaining access to affordable and high-quality vaccines is one of many challenges they face. Fully self-financing countries need to maintain their immunization programs while also committing increased funds for new vaccine introductions.
… ContinuedMeasles Outbreaks in an Interconnected World
Orin Levine, Director of Vaccine Delivery at the Bill and Melinda Gates Foundation, shared why he believes in vaccination in an early interview with The Optimist. He recently wrote a new piece for CBS on how resurgent measles outbreaks are underscoring the importance of vaccines. Please find an excerpt below, which originally appeared in February’s … Continued
UNICEF Immunization Financing in MENA Middle-Income Countries
Most Middle East and North Africa (MENA) countries have high immunization coverage rates. But immunization coverage has dropped considerably in some (including Iraq, the Syrian Arab Republic and Yemen), due to the conflicts, instability and the prevailing geopolitical situation in the region. Approximately 1.3 million surviving infants in MENA missed their third dose of DTP vaccine in 2016.
… ContinuedUpdated Template for Key Messages on ‘Why Investing in Immunization is a Priority’
New data on the equity impact of lives saved and medical impoverishment averted from immunization has been included in the template of key messages. Get the updated slidedeck template here, and access the original article here.
WHO Immunization Advocacy Resource Library
World Health Organization’s (WHO) Immunization advocacy library contains useful resources, information, and factsheets related to messaging on immunization and data on vaccination that can help immunization program managers and other stakeholders advocate for prioritization of immunization in political agendas and public health budgets.
… ContinuedGlobal Vaccine Action Plan (GVAP) 2011-2020
The Global Vaccine Action Plan (GVAP) is a framework approved by the World Health Assembly in May 2012 to achieve the Decade of Vaccines vision by delivering universal access to immunization. The mission outlined in the GVAP is straightforward: improve health by extending by 2020 and beyond the full benefits of immunization to all people, regardless of where they are born,
… Continued